Clinical trial Recruiting at 3 sites Observational Ages 50 to 80

Brain insulin resistance and brain health in people with diabetes

Official title: Disentangling the Effect of Brain Insulin Resistance on Brain Health (BIR-BrainHealth)

Run by Copenhagen University Hospital, Rigshospitalet · NCT07374705 · Data updated 2026-11-12

This project will test whether brains that don't respond well to insulin in people aged 50–80 with type 1 or type 2 diabetes are linked to worse thinking and structural brain changes compared with people without diabetes.

More Diabetes Type 2 trials

Quick facts

Study typeObservational
Ages50 Years to 80 Years
SexAll
Enrollment150 (estimated)
SponsorCopenhagen University Hospital, Rigshospitalet
Academic / other
Locations3 sites (Glostrup Municipality and 2 other locations)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedOctober 2031
Study endsJanuary 2032
Registry record updatedFebruary 25, 2026
Trial IDNCT07374705 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 50–80 with type 1 diabetes for at least 10 years or type 2 diabetes for at least 5 years who do not have dementia and meet the trial's safety and MRI eligibility criteria.

Probably not a fit

People with diagnosed dementia, recent major stroke, active recent cancer, uncontrolled psychiatric illness, severe sensory impairment, weight over 140 kg, or who cannot pause certain medications are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The multicenter project uses cognitive testing, advanced MRI scans, metabolic profiling, and multi-omics to explore whether brain insulin resistance (BIR) and cerebrovascular damage explain cognitive decline in diabetes. This registration covers the MRI components; PET imaging is not included here. The study plans to enroll about 50 people with type 1 diabetes, 50 with type 2 diabetes, and 50 control participants across sites in Denmark and Germany. Participants will be aged 50–80 and meet prespecified diabetes duration and safety criteria.

Why it matters

Potential benefit: If successful, the work could help identify patients at higher risk of cognitive decline and point to new prevention or treatment targets for diabetes-related brain problems.

How similar studies have gone: Smaller prior studies have suggested a link between brain insulin resistance and cognitive decline, but no large MRI-focused multicenter studies have yet confirmed this relationship.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (all):

* age 50-80 years

Inclusion Criteria (diabetes only):

* Diagnosis of either type 1 diabetes or type 2 diabetes
* Diabetes duration of ≥10 years for individuals with type 1 diabetes and ≥5 years for individuals with type 2 diabetes

Exclusion Criteria:

* HbA1c \>100 mmol/mol
* Other type of diabetes
* Weight \>140 Kg
* Treatment with drugs that cannot be paused for 12 hours
* Diagnosis of dementia
* Active and recent (1year) malignant disease
* History of major stroke
* Major depression and/or treatment with antipsychotics
* History of traumatic brain injury
* Other medical condition or disorder (e.g., epilepsy, recent concussion) that in the opinion of the investigator precludes compliance with the protocol, evaluation of the results or represent an unacceptable risk for the participant's safety.
* Inability to perform neuropsychological tests (e.g., severe vision and hearing impairment that cannot be improved with aids such as glasses and hearing aids, or language barrier.)
* Severe claustrophobia
* Foreign bodies of metal in the body which prohibits brain MRI scans (e.g. pacemaker or screws/plates from surgery in the head or neck region)
* Participants who do not wish to be informed about accidental findings by MRI
* eGFR measurement \<45 within 3 months of study visit

Where it's running

  • Rigshospitalet
    Glostrup Municipality, Denmark
    Recruiting
  • Steno Diabetes Center Copenhagen
    Herlev, Denmark
    Recruiting
  • University of Ulm
    Ulm, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.